TipRanks
Ligand Pharma (DE:LGDN)
FRANKFURT:LGDN
Germany Market
LGDN
Ligand Pharma
RESEARCH TOOLSreports

Ligand Pharma (LGDN) Balance Sheet

1 Followers

Ligand Pharma Balance Sheet

Ligand Pharma's total assets for Q2 2026 were $2.19B, an increase of 42.67% from the previous quarter. DE:LGDN total liabilities were $1.22B for the fiscal quarter, a 127.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.56B$ 941.77M$ 787.22M$ 762.67M$ 1.30B
Total Liabilities
$ 543.42M$ 111.33M$ 86.30M$ 165.18M$ 476.43M
Total Equity Gross Minority
$ 1.02B$ 830.44M$ 700.91M$ 597.49M$ 821.16M
Other Metrics
Currency in USD

Ligand Pharma Debt to Assets